These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10647076)

  • 1. Intermittent administration of brain-derived neurotrophic factor ameliorates glucose metabolism in obese diabetic mice.
    Ono M; Itakura Y; Nonomura T; Nakagawa T; Nakayama C; Taiji M; Noguchi H
    Metabolism; 2000 Jan; 49(1):129-33. PubMed ID: 10647076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent administration of brain-derived neurotrophic factor (BDNF) ameliorates glucose metabolism and prevents pancreatic exhaustion in diabetic mice.
    Yamanaka M; Itakura Y; Ono-Kishino M; Tsuchida A; Nakagawa T; Taiji M
    J Biosci Bioeng; 2008 Apr; 105(4):395-402. PubMed ID: 18499057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice.
    Yamanaka M; Itakura Y; Tsuchida A; Nakagawa T; Noguchi H; Taiji M
    Diabetes Obes Metab; 2007 Nov; 9(6):879-88. PubMed ID: 17924870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Lepr(db)/lepr(db) mice.
    Tonra JR; Ono M; Liu X; Garcia K; Jackson C; Yancopoulos GD; Wiegand SJ; Wong V
    Diabetes; 1999 Mar; 48(3):588-94. PubMed ID: 10078561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice.
    Nakagawa T; Tsuchida A; Itakura Y; Nonomura T; Ono M; Hirota F; Inoue T; Nakayama C; Taiji M; Noguchi H
    Diabetes; 2000 Mar; 49(3):436-44. PubMed ID: 10868966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain-derived neurotrophic factor ameliorates lipid metabolism in diabetic mice.
    Tsuchida A; Nonomura T; Nakagawa T; Itakura Y; Ono-Kishino M; Yamanaka M; Sugaru E; Taiji M; Noguchi H
    Diabetes Obes Metab; 2002 Jul; 4(4):262-9. PubMed ID: 12099975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of brain-derived neurotrophic factor on pancreatic islets in obese diabetic mice.
    Yamanaka M; Itakura Y; Inoue T; Tsuchida A; Nakagawa T; Noguchi H; Taiji M
    Metabolism; 2006 Oct; 55(10):1286-92. PubMed ID: 16979397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-derived neurotrophic factor reduces blood glucose level in obese diabetic mice but not in normal mice.
    Ono M; Ichihara J; Nonomura T; Itakura Y; Taiji M; Nakayama C; Noguchi H
    Biochem Biophys Res Commun; 1997 Sep; 238(2):633-7. PubMed ID: 9299565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of brain-derived neurotrophic factor on energy expenditure in obese diabetic mice.
    Tsuchida A; Nonomura T; Ono-Kishino M; Nakagawa T; Taiji M; Noguchi H
    Int J Obes Relat Metab Disord; 2001 Sep; 25(9):1286-93. PubMed ID: 11571589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium meta-arsenite ameliorates hyperglycemia in obese diabetic db/db mice by inhibition of hepatic gluconeogenesis.
    Lee YS; Lee EK; Oh HH; Choi CS; Kim S; Jun HS
    J Diabetes Res; 2014; 2014():961732. PubMed ID: 25610880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-derived neurotrophic factor (BDNF) regulates glucose and energy metabolism in diabetic mice.
    Nakagawa T; Ono-Kishino M; Sugaru E; Yamanaka M; Taiji M; Noguchi H
    Diabetes Metab Res Rev; 2002; 18(3):185-91. PubMed ID: 12112936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain-derived neurotrophic factor regulates energy expenditure through the central nervous system in obese diabetic mice.
    Nonomura T; Tsuchida A; Ono-Kishino M; Nakagawa T; Taiji M; Noguchi H
    Int J Exp Diabetes Res; 2001; 2(3):201-9. PubMed ID: 12369708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-obesity and anti-diabetic effects of brain-derived neurotrophic factor in rodent models of leptin resistance.
    Nakagawa T; Ogawa Y; Ebihara K; Yamanaka M; Tsuchida A; Taiji M; Noguchi H; Nakao K
    Int J Obes Relat Metab Disord; 2003 May; 27(5):557-65. PubMed ID: 12704399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain-derived neurotrophic factor enhances glucose utilization in peripheral tissues of diabetic mice.
    Yamanaka M; Tsuchida A; Nakagawa T; Nonomura T; Ono-Kishino M; Sugaru E; Noguchi H; Taiji M
    Diabetes Obes Metab; 2007 Jan; 9(1):59-64. PubMed ID: 17199719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain-derived neurotrophic factor modulates glucagon secretion from pancreatic alpha cells: its contribution to glucose metabolism.
    Hanyu O; Yamatani K; Ikarashi T; Soda S; Maruyama S; Kamimura T; Kaneko S; Hirayama S; Suzuki K; Nakagawa O; Nawa H; Aizawa Y
    Diabetes Obes Metab; 2003 Jan; 5(1):27-37. PubMed ID: 12542722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain-derived neurotrophic factor (BDNF) prevents the development of diabetes in prediabetic mice.
    Yamanaka M; Itakura Y; Tsuchida A; Nakagawa T; Taiji M
    Biomed Res; 2008 Jun; 29(3):147-53. PubMed ID: 18614848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actions of the novel oral antidiabetic agent HQL-975 in genetically obese diabetic db/db mice.
    Ishikawa Y; Takagi Y; Takeno H; Watanabe K; Tani T
    Biol Pharm Bull; 1998 Sep; 21(9):928-33. PubMed ID: 9781841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice.
    Lin B; Koibuchi N; Hasegawa Y; Sueta D; Toyama K; Uekawa K; Ma M; Nakagawa T; Kusaka H; Kim-Mitsuyama S
    Cardiovasc Diabetol; 2014 Oct; 13():148. PubMed ID: 25344694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta).
    Young AA; Gedulin BR; Bhavsar S; Bodkin N; Jodka C; Hansen B; Denaro M
    Diabetes; 1999 May; 48(5):1026-34. PubMed ID: 10331407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combined effect of triple therapy with rosiglitazone, metformin, and insulin aspart in type 2 diabetic patients.
    Poulsen MK; Henriksen JE; Hother-Nielsen O; Beck-Nielsen H
    Diabetes Care; 2003 Dec; 26(12):3273-9. PubMed ID: 14633813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.